Related Experiment Videos
Jun-B oncogene aberrations in cervical cancer cell lines
K B Choo1, C J Huang, C M Chen
1Department of Medical Research, Veterans General Hospital, Taipei, Taiwan.
Cancer Letters
|July 13, 1995
Summary
Altered jun-B oncogene expression, linked to human papillomavirus (HPV) and chromosomal changes, may drive cervical cancer progression in cell lines. These jun-B gene alterations were observed in CC7T-a and HeLa cells.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The jun-B oncogene plays a role in cellular processes.
- Cervical cancer is often associated with human papillomavirus (HPV) infections.
- Understanding gene alterations in cancer is crucial for identifying therapeutic targets.
Purpose of the Study:
- To investigate the structural and expression status of the jun-B oncogene in cervical cancer cell lines.
- To determine the potential role of jun-B gene alterations in cervical cancer development.
Main Methods:
- Southern analysis to detect gene structure alterations.
- cDNA cloning to identify jun-B gene variants.
- Analysis of jun-B gene expression levels.
- Investigating the association with human papillomavirus (HPV) integration.
Main Results:
- CC7T-a cell line showed two structurally altered jun-B alleles: one due to HPV-16 integration and another from chromosomal translocation.
- HeLa cell line exhibited a 3-fold amplification and 3-fold overexpression of the jun-B gene, with integrated HPV-18.
- These findings indicate jun-B gene deregulation in the studied cervical cancer cell lines.
Conclusions:
- Aberrant jun-B gene structure and expression are present in cervical cancer cell lines.
- HPV integration and chromosomal translocations contribute to jun-B alterations.
- Deregulation of jun-B may be implicated in the transformation process of cervical cancer.